Lamotrigine brand change

Lamotrigine is used to treat epilepsy and some mental health conditions, such as bipolar disorder.

Dose changes and nominated pharmacy

You can dispense lamotrigine at a dose different to that specified on the approval. You do not need to tell or seek approval from PHARMAC.

Any pharmacy can dispense and claim for lamotrigine with an exceptional circumstances approval. There is no need to have a nominated pharmacy for lamotrigine.

Applications to fund Arrow-Lamotrigine and Lamictal

  • Total number of patients: 2,526
  • Applications under assessment: 21
  • Approved: 2,418
  • Declined: 78
  • Withdrawn: 9

(last updated August 2020)

The number of declined applications has increased because dispensing data indicated that these applications were for people who:

  • were not previously on another brand of lamotrigine and for who Logem is an appropriate treatment option or
  • had not been prescribed lamotrigine for mental health or epilepsy indications. 

Read the criteria for funding alternative brands of lamotrigine

Media releases and OIA responses